Tilianin attenuates inflammasome activation in endothelial progenitor cells to mitigate myocardial ischemia-reperfusion injury

Miaomiao Wang(Shihezi University), Jianguo Xing(Xinjiang Institute of Materia Medica), Hu Xu(Beijing Radiation Center), Jiapeng Li(China Pharmaceutical University), Xiao-Xue Li(Southeast University), Mengmeng Fu(China Pharmaceutical University), Ming Xu(Mayo Clinic in Florida), Davaadagva Damdinjave(Mongolian National University of Medical Sciences), Ruifang Zheng(Xinjiang Institute of Materia Medica)
PLoS ONE
October 10, 2024
Cited by 3


Related Papers